Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar

Not Applicable

Completed

• Conditions: Hypertension; Behavioral Lifestyle Change; Diabetes Mellitus, Type II; Overweight and Obesity; Social Change
• Interventions: Behavioral: Microclinic Social Induction Diabetes and Obesity Program

• Registration Number: NCT02175537
• Lead Sponsor: Microclinic International

Brief Summary

The purpose of the study is to pilot-phase test the effectiveness of the microclinic social induction model and its effects on behavioral and metabolic outcomes in different levels of social and familial relationships in Qatar. The investigators novel microclinic model is based on the principle that both healthy and unhealthy behaviors spread through preexisting social networks. A microclinic is a small group of approximately 2-8 friends or family members who are taught to modify their own behaviors as well as the behaviors of those around them, with a particular focus on the four "M's": Meals, Movement, Monitoring, and Medication. More than social support groups or peer-to-peer interventions, the microclinic model is unique in its focus on the long-term propagation of healthy behaviors throughout a participant's entire social network. Qatar is uniquely positioned (with its central geographic location in the Gulf region and its leadership in science and education) to spearhead a regional intervention focused on managing and preventing diabetes in the Gulf region.

Detailed Description

This pilot study, "Microclinic Social Induction Intervention for Diabetes and Obesity Management in Qatar," is a two-arm randomized controlled trial of a 7-week condensed intervention to evaluate the efficacy of the microclinic social induction model on propagating lifestyle changes and in improving glycemic and metabolic control in Doha, Qatar.

The microclinic social induction model leverages different levels of social and familial relationships to positively influence behaviors relating to diabetes and other metabolic conditions through small treatment units called 'microclinic groups,' consisting of 2-8 peers and family members of the same social network. The intervention model brings microclinic groups to a larger classroom network (\~25 people/class) where each class shares access to a culturally salient diabetes educational curriculum and group support to promote health behavior changes such as improvement in diet, exercise, medication adherence, and blood pressure management to then influence better glycemic and metabolic control.

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2014-06-18
• Study First Submitted QC: 2014-06-25
• Study First Posted: 2014-06-26
• Primary Completion: 2014-11
• Study Completion: 2014-11
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-18
• Last Update Posted: 2014-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Over 18 years old
• Mentally competent
• Body Mass Index of 30 or higher
• Body Mass Index of 25 or higher and self-reported pre-diabetes or type II diabetes

Exclusion Criteria

• They do not meet the above criteria
• They are pregnant
• They have significant medical complications that prevent them from making changes to diet or level of physical activity.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Microclinic social induction training	Microclinic Social Induction Diabetes and Obesity Program	BMI of 30 and over; or BMI of 25 and over and self-reported pre-diabetes or type II diabetes will receive the Microclinic Social Induction Diabetes and Obesity Program. The intervention is a training on diabetes self-management, disease monitoring, diabetes prevention, prevention of complications, health behavior change, and social network supports in order to improve chronic disease risk factors.

Primary Outcome Measures

Name	Time	Method
Waist circumference	Baseline, 4th-week midpoint, 7th-week final
Weight	Weekly measurements between baseline and end of trial after 7 weeks	Change in body weight (and BMI)
HbA1c	Baseline, end of trial after 7 weeks	Change in HbA1c from baseline to end of 7-week pilot phase.

Secondary Outcome Measures

Name	Time	Method
Blood Pressure	Baseline, 4th-week midpoint, 7th-week final	Systolic and diastolic blood pressure changes
Health Profile Survey	Baseline, end of trial after 7 weeks.	Change in overall health seeking and health maintenance behaviors.

Trial Locations

Locations (1)

Qatar Diabetes Association; 🇶🇦 Doha, Qatar